DDM-019 - Convolution approach to evaluate amiodarone-HCl solid oral dosage forms

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: DDM-019
• By: CONTRERAS JIMéNEZ, Juan Manuel (Universidad Autónoma Metropolitana, Mexico)
• Co-author(s): Mr Juan Manuel Contreras Jiménez (Universidad Autónoma Metropolitana, Mexico City, Mexico)
  Mr Jonathan Lara-Veloz
  Master José Raúl Medina-López
  
• Abstract:

  Introduction: Amiodarone-HCl (AMD) is suggested for the treatment of life threating ventricular and supraventricular arrhythmias as well as atrial fibrillation. To treat these diseases the tablet formulation is recommended. AMD is a compound with low solubility (0.35 mg/mL), high permeability, high protein binding (> 96%) and moderate..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login